DYMAXIUM
DEAD

Serial Number

77833279

Owner

XCENDA, L.L.C.

Attorney

Patrick C. Stephenson

Filing Date

Sep 23, 2009

Add to watchlist:

No watchlists yet
View on USPTO

DYMAXIUM Trademark

Serial Number: 77833279 • Registration: 4122194

DYMAXIUM is a trademark filed by XCENDA, L.L.C. on September 23, 2009. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

XCENDA, L.L.C. (18 trademarks)

Suite 500
Palm Harbor, FL 34685

Entity Type: 16

DYMAXIUM HOLDINGS, LTD. (3 trademarks)

227 WASHINGTON STREET
CONSHOHOCKEN, PA 19428

Entity Type: 03

Dymaxium Inc. (4 trademarks)

Suite 306
Toronto, Ontario M5A1E3 , CA

Entity Type: 03

Trademark Details

Filing Date

September 23, 2009

Registration Date

April 3, 2012

Published for Opposition

November 2, 2010

Cancellation Date

October 14, 2022

Goods & Services

Non-downloadable electronic instructional and marketing publications, namely, published research abstracts, research posters, slides, reports, user manuals, instructional brochures, marketing brochures, handouts, periodicals, newsletters, reprint articles, training guides and tutorials, instructional resource cards, flow charts and diagrams, for use in the healthcare, medical, pharmaceutical and biotechnology fields; providing web sites that feature non-downloadable electronic instructional and marketing publications, namely, published research abstracts, research posters, slides, reports, user manuals, instructional brochures, marketing brochures, handouts, periodicals, newsletters, reprint articles, training guides and tutorials, instructional resource cards, flow charts and diagrams, for use in the healthcare, medical, pharmaceutical and biotechnology fields

Software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; downloadable electronic instructional and marketing publications, namely, published research abstracts, research posters, slides, reports, user manuals, instructional brochures, marketing brochures, handouts, periodicals, newsletters, reprint articles, training guides and tutorials, instructional resource cards, flow charts and diagrams, for use in the healthcare, medical, pharmaceutical and biotechnology fields

Printed instructional and marketing publications, namely, published research abstracts, research posters, slides, reports, user manuals, instructional brochures, marketing brochures, handouts, periodicals, newsletters, reprint articles, training guides and tutorials, instructional resource cards, flow charts and diagrams, for use in the healthcare, medical, pharmaceutical and biotechnology fields

Consulting and research services in the areas of health economics and outcomes

Providing information in the healthcare, medical and pharmaceutical fields to help improve processes focused on the clinical, economic and humanistic outcomes; consulting and research services in the pharmaceutical, healthcare and medical fields

Development of software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; development of non-downloadable web-based software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; providing use of non-downloadable software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; providing use of non-downloadable web-based software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; providing non-downloadable web-based software, namely, dossier software for searching, filtering and reviewing information within product dossiers, data analysis and outcome analyzer tool software for analyzing data and outcomes, economic model software for assessing economic outcomes, budget impact and cost-effectiveness of products, and health-related communication and educational software all for asking questions, generating requests, obtaining feedback, sharing best practices and resources and for conducting on-line surveys, all for use in healthcare, medical, pharmaceutical and biotechnology fields; providing technical support services, namely, troubleshooting of computer software problems relating to non-downloadable web-based software, namely, dossier software for searching, filtering and reviewing information within product dossiers, data analysis and outcome analyzer tool software for analyzing data and outcomes, economic model software for assessing economic outcomes, budget impact and cost-effectiveness of products, and health-related communication and educational software all for asking questions, generating requests, obtaining feedback, sharing best practices and resources and for conducting on-line surveys, all to help improve processed focused on clinical, economic, and humanistic outcomes all in the healthcare, medical, pharmaceutical and biotechnology fields; providing information in the biotechnology field to help improve processes focused on clinical, economic, and humanistic outcomes; consulting and research services in the biotechnology fields; non-downloadable web-based software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Oct 14, 2022 CAEX
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2021 REAP
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 3, 2021 REM2
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Jun 11, 2020 CORV
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 27, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 27, 2020 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Apr 27, 2020 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 27, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 27, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 27, 2020 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 9, 2019 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 7, 2019 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 11, 2018 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 11, 2018 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 11, 2018 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 2, 2018 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 3, 2017 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 19, 2015 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 19, 2015 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 16, 2013 TCCA
REGISTERED-PRINCIPAL REGISTER
Apr 3, 2012 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 29, 2012 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Feb 28, 2012 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 21, 2012 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 23, 2012 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 23, 2012 AITU
USE AMENDMENT FILED
Dec 21, 2011 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 21, 2011 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 29, 2011 EXRA
SOU EXTENSION 1 GRANTED
Jun 27, 2011 EX1G
SOU EXTENSION 1 FILED
Jun 27, 2011 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 27, 2011 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 28, 2010 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2010 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 27, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 27, 2010 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 27, 2010 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 27, 2010 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 27, 2010 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2010 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2010 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2010 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 30, 2010 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 27, 2010 PBCR
TEAS POST PUBLICATION AMENDMENT RECEIVED
Aug 24, 2010 EPPA
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 19, 2010 PREV
ASSIGNED TO LIE
Aug 19, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 2, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 2, 2010 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 2, 2010 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 2, 2010 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 2, 2010 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 1, 2010 GNRN
NON-FINAL ACTION E-MAILED
Jul 1, 2010 GNRT
NON-FINAL ACTION WRITTEN
Jul 1, 2010 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 9, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2009 GNRN
NON-FINAL ACTION E-MAILED
Dec 20, 2009 GNRT
NON-FINAL ACTION WRITTEN
Dec 20, 2009 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2009 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Sep 28, 2009 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 28, 2009 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2009 NWOS
NEW APPLICATION ENTERED
Sep 26, 2009 NWAP